I 
117TH CONGRESS 
1ST SESSION H. R. 6106 
To amend title III of the Public Health Service Act to terminate the effective 
time period for immunity for manufacturers of COVID–19 vaccines, 
and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
DECEMBER 1, 2021 
Mr. GOODEN of Texas introduced the following bill; which was referred to the 
Committee on Energy and Commerce 
A BILL 
To amend title III of the Public Health Service Act to 
terminate the effective time period for immunity for 
manufacturers of COVID–19 vaccines, and for other pur-
poses. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. LIABILITY OF COVID–19 VACCINE MANUFAC-
3
TURERS. 
4
Notwithstanding any other provision of law, in apply-
5
ing section XII of the ‘‘Declaration Under the Public 
6
Readiness and Emergency Preparedness Act for Medical 
7
Countermeasures Against COVID–19’’ issued pursuant to 
8
VerDate Sep 11 2014 
23:17 Dec 09, 2021
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H6106.IH
H6106
kjohnson on DSK79L0C42PROD with BILLS
2 
•HR 6106 IH
section 319F–3(b)(2)(B) of the Public Health Service Act 
1
(42 U.S.C. 247d–6d(b)(2)(B)), with respect to manufac-
2
turers of COVID–19 vaccines, the reference to October 1, 
3
2024, shall be deemed a reference to December 1, 2021. 
4
Æ 
VerDate Sep 11 2014 
23:17 Dec 09, 2021
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H6106.IH
H6106
kjohnson on DSK79L0C42PROD with BILLS
